AdBio partners’ Post

View organization page for AdBio partners, graphic

3,592 followers

[AdBio news] We are thrilled to announce that Emma Gasol Escuer, PhD, has been promoted to Partner ! Emma’s extensive experience in the #pharma and #biotech industry, coupled with her strategic and entrepreuneurial mindset, makes her a valuable addition to our leadership team. 📌Emma joined AdBio in 2023, bringing over 20 years of experience in business development, transaction, and innovation management. 👑 Her track record includes a range of transactions from early development to commercial stage, such as in-licensing, co-development, option rights, and acquisitions. 🌐Emma started her career at Crystax Pharma and later joined Gebro, where she led Corporate Development activities. Prior to joining AdBio partners, she was Director of Innovation Scouting at Grifols, demonstrating her ability to drive deal sourcing and identify cutting-edge technologies. Join us in celebrating Emma ! 🙌 #AdBioPartners #BiotechInnovation #LifeSciences #TeamAnnouncement

Pascal George, PhD, MRSC

Scientific Expert and Adviser in Drug Discovery & Development - Former Head of CNS Med Chem Sanofi, former President of the French medicinal chemistry Society

4mo

Congratulation Emma, happy to see you again for further adventures

Itziar Escudero

Enterprise Account Executive at TraceLink

4mo

Felicidades Emma! Un abrazo!

Sara Montero López

Managing Director LATAM North & South

4mo

Congratulations Emma Gasol Escuer!!! Well deserved👏🏻👏🏻👏🏻

Jordi Sarrà Herrera

Head of Business Development at Leanbio Pro

4mo

Enhorabona!!

Jean-Baptiste Duval

M&A Operation Executive Biotech-Pharma-Healthcare-Life Sciences Professional

4mo

Congrats Emma Gasol Escuer ! Time flies since Gebro ⏱️

Like
Reply
Natalia Novac

Investor | Corporate and Private Venture Capital | Board Member | Startup Coach | Business Developer | ex - Eli Lilly | ex - Merck

4mo

Congratulations Emma! Well deserved!

Erica Stone

Vice President, Oncology

4mo

Congratulations Emma Gasol Escuer!

See more comments

To view or add a comment, sign in

Explore topics